AIDS clinical trials /

Bibliographic Details
Other Authors: Finkelstein, Dianne M., Schoenfeld, David A.
Format: Book
Language:English
Published: New York : Wiley-Liss, [1995]
Subjects:
Table of Contents:
  • Introduction
  • The natural history of the HIV infection: Implications for clinical trials
  • The new drug evaluation process: FDA perspective
  • The new drug evaluation process: Industry perspective
  • Protocol development
  • Data issues in AIDS clinical trials
  • Current methods and future trends in the design and analysis of phase I and phase I/II clinical trials in AIDS
  • Selection of endpoints for assessment of treatment efficacy in an AIDS trial
  • The uses of CD4 lymphocyte count to evaluate therapy for HIV disease
  • Sample size calculations for failure time data
  • The design and analysis of equivalence trials
  • Interim monitoring of clinical trials
  • Behavioral science and the design and conduct of randomized AIDS trials
  • Compliance in AIDS clinical trials.
  • Quality-of-life considerations in AIDS clinical trials
  • Issues in analysis of AIDS clinical trials
  • Issues in the testing of drug combinations
  • Issues in the conduct of clinical trials for HIV-infected children.
  • Clinical trials to reduce the risk of maternal-infant transmission of HIV infection
  • Obstetrical and gynecological issues in AIDS clinical trials
  • Prophylactic HIV vaccine trials
  • Large simple trials of HIV therapies
  • Economic analysis and AIDS clinical research
  • Use of observational data for evaluating AIDS therapies
  • Use of cohort studies for evaluating AIDS therapies.